Cargando…
Assessment of antiphospholipid antibodies profiles based on severity of COVID-19 pneumonia
INTRODUCTION: thrombotic events are the most severe complications of the coronavirus disease 2019 (COVID-19). It is known that anti-phospholipid antibodies (APL) could be involved in thrombosis mechanism. Thus, APL profiles were studied particularly in patients with severe and critical COVID-19, and...
Autores principales: | Bnina, Amène Ben, Dhia, Refka Ben, Gnaba, Sahar, Annabi, Alaa, Chouchane, Syrine, Naija, Walid, Said, Houyem, Oueslati, Abderraouf, Bouatay, Amina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The African Field Epidemiology Network
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392000/ https://www.ncbi.nlm.nih.gov/pubmed/36034019 http://dx.doi.org/10.11604/pamj.2022.42.110.33020 |
Ejemplares similares
-
Association between Human Leukocyte Antigen (HLA) DQB1*06 and HLA DQB1*03 and adverse outcomes in a group of critically ill patients with COVID-19 in Tunisia: a cross-sectional study
por: Bnina, Amène Ben, et al.
Publicado: (2023) -
Antiphospholipid antibodies in autoimmune thyroid diseases
por: Mankaï, Amani, et al.
Publicado: (2022) -
Staphylococcus aureus Ventilator-Associated Pneumonia: A Study of Bacterio-Epidemiological Profile and Virulence Factors
por: Tilouche, Lamia, et al.
Publicado: (2021) -
Antiphospholipid antibodies and thrombosis: pathogenesis of antiphospholipid syndrome
por: Koike, T
Publicado: (2003) -
Role of antiphospholipid antibodies in the diagnosis of antiphospholipid syndrome
por: Devreese, Katrien M.J., et al.
Publicado: (2021)